Folgen
Jason Nelson
Titel
Zitiert von
Zitiert von
Jahr
Vitamin D supplementation and prevention of type 2 diabetes
AG Pittas, B Dawson-Hughes, P Sheehan, JH Ware, WC Knowler, ...
New England journal of medicine 381 (6), 520-530, 2019
7442019
The Boston Puerto Rican Health Study, a longitudinal cohort study on health disparities in Puerto Rican adults: challenges and opportunities
KL Tucker, J Mattei, SE Noel, BM Collado, J Mendez, J Nelson, J Griffith, ...
BMC Public health 10, 1-12, 2010
2582010
Plasma 25-hydroxyvitamin D and progression to diabetes in patients at risk for diabetes: an ancillary analysis in the Diabetes Prevention Program
AG Pittas, J Nelson, J Mitri, W Hillmann, C Garganta, DM Nathan, FB Hu, ...
Diabetes care 35 (3), 565-573, 2012
2442012
Intratrial exposure to vitamin D and new-onset diabetes among adults with prediabetes: a secondary analysis from the vitamin D and type 2 diabetes (D2d) study
B Dawson-Hughes, MA Staten, WC Knowler, J Nelson, EM Vickery, ...
Diabetes care 43 (12), 2916-2922, 2020
1962020
Heterogeneity of treatment effects in an analysis of pooled individual patient data from randomized trials of device closure of patent foramen ovale after stroke
DM Kent, JL Saver, SE Kasner, J Nelson, JD Carroll, G Chatellier, ...
Jama 326 (22), 2277-2286, 2021
1802021
Geographic access to burn center hospitals
MB Klein, CB Kramer, J Nelson, FP Rivara, NS Gibran, T Concannon
Jama 302 (16), 1774-1781, 2009
1572009
Risk and treatment effect heterogeneity: re-analysis of individual participant data from 32 large clinical trials
DM Kent, J Nelson, IJ Dahabreh, PM Rothwell, DG Altman, RA Hayward
International journal of epidemiology 45 (6), 2075-2088, 2016
1542016
Improving diabetes prevention with benefit based tailored treatment: risk based reanalysis of Diabetes Prevention Program
JB Sussman, DM Kent, JP Nelson, RA Hayward
Bmj 350, 2015
1492015
Vitamin D and risk for type 2 diabetes in people with prediabetes: a systematic review and meta-analysis of individual participant data from 3 randomized clinical trials
AG Pittas, T Kawahara, R Jorde, B Dawson-Hughes, EM Vickery, ...
Annals of internal medicine 176 (3), 355-363, 2023
1342023
A percutaneous coronary intervention lab in every hospital?
TW Concannon, J Nelson, J Goetz, JL Griffith
Circulation: Cardiovascular Quality and Outcomes 5 (1), 14-20, 2012
1122012
Vitamin D status of black and white Americans and changes in vitamin D metabolites after varied doses of vitamin D supplementation
NS Alzaman, B Dawson-Hughes, J Nelson, D D’Alessio, AG Pittas
The American journal of clinical nutrition 104 (1), 205-214, 2016
1082016
Using internally developed risk models to assess heterogeneity in treatment effects in clinical trials
JF Burke, RA Hayward, JP Nelson, DM Kent
Circulation: Cardiovascular Quality and Outcomes 7 (1), 163-169, 2014
932014
Vitamin D supplementation in patients with type 2 diabetes: the vitamin D for established type 2 diabetes (DDM2) study
E Angellotti, D D’Alessio, B Dawson-Hughes, J Nelson, RM Cohen, ...
Journal of the Endocrine Society 2 (4), 310-321, 2018
682018
Effects of vitamin D supplementation on insulin sensitivity and secretion in prediabetes
N Rasouli, IG Brodsky, R Chatterjee, SH Kim, RE Pratley, MA Staten, ...
The Journal of Clinical Endocrinology & Metabolism 107 (1), 230-240, 2022
622022
External validations of cardiovascular clinical prediction models: a large-scale review of the literature
BS Wessler, J Nelson, JG Park, H McGinnes, G Gulati, R Brazil, ...
Circulation: Cardiovascular Quality and Outcomes 14 (8), e007858, 2021
612021
Comparative outcomes of β-lactam antibiotics in outpatient parenteral antibiotic therapy: treatment success, readmissions and antibiotic switches
B Lee, I Tam, B Weigel IV, JL Breeze, JK Paulus, J Nelson, GM Allison
Journal of Antimicrobial Chemotherapy 70 (8), 2389-2396, 2015
612015
Evidence of systematic duplication by new percutaneous coronary intervention programs
TW Concannon, J Nelson, DM Kent, JL Griffith
Circulation: Cardiovascular Quality and Outcomes 6 (4), 400-408, 2013
602013
Large-scale validation of the prediction model risk of bias assessment Tool (PROBAST) using a short form: high risk of bias models show poorer discrimination
E Venema, BS Wessler, JK Paulus, R Salah, G Raman, LY Leung, ...
Journal of clinical epidemiology 138, 32-39, 2021
542021
Association between body weight and composition and plasma 25-hydroxyvitamin D level in the Diabetes Prevention Program
L Ceglia, J Nelson, J Ware, KD Alysandratos, GA Bray, C Garganta, ...
European journal of nutrition 56 (1), 161-170, 2017
542017
Generalizability of cardiovascular disease clinical prediction models: 158 independent external validations of 104 unique models
G Gulati, J Upshaw, BS Wessler, RJ Brazil, J Nelson, D Van Klaveren, ...
Circulation: Cardiovascular Quality and Outcomes 15 (4), e008487, 2022
462022
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20